Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

PCOS diagnosis and treatment should consider race and ethnicity for accuracy.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Hair loss may indicate higher heart risk and metabolic issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Metformin helps manage PCOS by improving fertility and is safe for pregnancy, especially when combined with certain treatments.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

New treatments for PCOS focus on managing symptoms and improving fertility.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.